EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
65 hedge funds and large institutions have $31.9M invested in Eagle Pharmaceuticals, Inc. in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
61% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 28
Holders
65
Holding in Top 10
–
Calls
$3.74M
Puts
$4K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$453K | |
| 3 | +$212K | |
| 4 |
A
AJOVista
Boston,
Massachusetts
|
+$169K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$104K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.2M | |
| 3 | -$1.02M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$971K |
| 5 |
Millennium Management
New York
|
-$940K |